HBM is a China-based biopharmaceutical company that discovers and develops immuno-oncology therapeutics for the treatment of cancer and inflammatory diseases... Read more
HBM is a China-based biopharmaceutical company that discovers and develops immuno-oncology therapeutics for the treatment of cancer and inflammatory diseases... Read more
News
investment
Jan 17, 2026
https://www.prnewswire.com/news-releases/harbour-biomed-acquires-common-stock-in-spruce-biosciences-deepening-strategic-collaboration-302664109.html
Harbour BioMed Shanghai & Co., Ltd. has invested $0 in Spruce Biosciences, Inc..
Partnership
Jan 02, 2026
Contract Pharma
Harbour BioMed, Lannacheng Partner to Advance Next-Gen RDCs
Harbour BioMed Competitors
1
2
3
4
5
6
7
8
9
10